Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.00 is 136% above its 2-year average of -0.01, near the high end of its 2-year range (-0.09–0.04).
As of the fiscal period ended Wednesday, December 31, 2025. 126.75% above its 12-month average of -0.02.
Reported quarterly debt to equity ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
-0.02
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+126.75%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 704 covered companies
CURRENT VS SECTOR MEDIAN
-95.77%
vs the sector median at left
Market Cap
$3.13M
Debt to Equity Ratio
0.01
TTM Avg
0.05
3Y Avg
0.04
5Y Avg
0.04
Market Cap
$3.23M
Debt to Equity Ratio
N/A
TTM Avg
1.28
3Y Avg
1.28
5Y Avg
0.64
Market Cap
$3.23M
Debt to Equity Ratio
0.02
TTM Avg
0.06
3Y Avg
0.17
5Y Avg
0.12
Market Cap
$3.12M
Debt to Equity Ratio
0.07
TTM Avg
0.04
3Y Avg
0.02
5Y Avg
0.02
Market Cap
$3.29M
Debt to Equity Ratio
0.07
TTM Avg
0.10
3Y Avg
0.11
5Y Avg
0.08
Market Cap
$3.00M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.01
5Y Avg
0.02
Market Cap
$3.40M
Debt to Equity Ratio
7.21
TTM Avg
1.21
3Y Avg
0.62
5Y Avg
0.62
Market Cap
$3.42M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBody AI Ltd. (MBAI) | $3.18M | 0.00 | -0.02 | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | 0.01 | 0.05 | 0.04 | 0.04 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | N/A | 1.28 | 1.28 | 0.64 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | 0.02 | 0.06 | 0.17 | 0.12 |
| Revelation Biosciences, Inc. (REVB)vs › | $3.12M | 0.07 | 0.04 | 0.02 | 0.02 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | 0.07 | 0.10 | 0.11 | 0.08 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.00M | 0.01 | 0.00 | 0.01 | 0.02 |
| Moolec Science S.A. (MLEC)vs › | $3.40M | 7.21 | 1.21 | 0.62 | 0.62 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 0.00 | 0.00 | 0.00 | 0.00 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00 | 0.00 | 7.00 | 4.21 |
Debt/Equity
0.00
Current Ratio
0.05
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2025-12-31 | 0.00 |
| 2025-06-30 | 0.04 |
| 2024-12-31 | -0.09 |
| 2024-06-30 | 0.00 |
